Everyday health

Professor Lauren Ball writes about scurvy making a comeback in developed countries for the Conversation.

Professor Paul Griffin writes about how the covid vaccines are going to prepare humanity for the next pandemic.

Dr Sebastian Furness from the School of Biomedical Sciences writes about liraglutide for the Conversation.

Professor Coral Gartner writes about the implications of pharmacists being allowed to supply vapes for the Conversation.

Professor Lauren Ball and Dr Breanna Lepre from the School of Public Health discuss why autistic people and those with ADHD are more likely to have eating disorders via the Conversation.

Dr Sophie Wen discusses the implications of Australians not being able to access no-fault compensation for vaccine injuries from the end of this month via the Conversation.

Professor Lauren Ball and Ms Evangeline Gardiner from the School of Public Health write about the changing perceptions of obesity and body weight via the Conversation.

Professor Paul Griffin writes about the new COVID vaccines that may be coming to Australia soon via the Conversation.

People who are taller are at greater risk of developing cancer. But why? Here’s what we know, don’t know and suspect.

The weight-loss drug Wegovy is now available in Australia. So how does Wegovy work and how much weight can you expect to lose while taking it? And what are the potential risks – and costs – for those who use it?